Drug intelligence / Profile preview

BSL_EP027

Development stage: Preclinical
Lead developer: Biosearch
Administration: Oral

Overview

**BSL_EP027** is a proprietary orally consumed botanical mixture developed by Biosearch for prevention of respiratory infection symptoms in older adults. It consists of a combination of plant extracts supplied as a sachet dissolved in water; the specific botanical constituents, standardization, and molecular targets have not been publicly disclosed. In the completed registered study NCT04386408, daily administration was evaluated in healthy elderly nursing-home residents for effects on the incidence and duration of respiratory infection symptoms.

Beyond the preview

Go deeper on BSL_EP027.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BSL_EP027.

Explore the full profile